Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Hamer

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Molecular & General Genetics : MGG|January 1, 1985
Primary structure of the trpC gene from Aspergillus nidulansE J Mullaney, J E Hamer, K A Roberti, et al.
Therapeutic Advances in Hematology|March 27, 2026
Ruxolitinib treatment in patients with polycythemia vera reduces <i>JAK2</i> variant allele frequency and improves symptom burden and hematocrit controlClaire N Harrison, Jean-Jacques Kiladjian, J E Hamer-Maansson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1983
Developmental regulation of the Aspergillus nidulans trpC geneM M Yelton, J E Hamer, E R de Souza, et al.
The Plant Cell|June 1, 1996
MPG1 Encodes a Fungal Hydrophobin Involved in Surface Interactions during Infection-Related Development of Magnaporthe griseaN. J. Talbot, M. J. Kershaw, G. E. Wakley, et al.
Cancer|February 25, 2023
Early intervention in myelofibrosis and impact on outcomes: A pooled analysis of the COMFORT-I and COMFORT-II studiesSrdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M Vannucchi, et al.
Diabetes, Obesity & Metabolism|September 10, 2014
Twice-daily dapagliflozin co-administered with metformin in type 2 diabetes: a 16-week randomized, placebo-controlled clinical trialP-M Schumm-Draeger, L Burgess, L Korányi, et al.
Acta Haematologica|July 13, 2025
Impact of Early-Onset or Worsening Anemia in Patients with Myelofibrosis Treated with Ruxolitinib: A post hoc Analysis of the JUMP StudyHaifa Kathrin Al-Ali, Paola Guglielmelli, Claire N Harrison, et al.
The EMBO Journal|December 22, 1999
Interaction between developmental and cell cycle regulators is required for morphogenesis in Aspergillus nidulansX S Ye, S L Lee, T D Wolkow, et al.
Ejhaem|August 19, 2024
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysisMichael R Grunwald, Ellen K Ritchie, Elisa Rumi, et al.
Blood|December 24, 2023
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEALAaron T Gerds, Ruben Mesa, John M Burke, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Molecular & General Genetics : MGG|January 1, 1985
Primary structure of the trpC gene from Aspergillus nidulansE J Mullaney, J E Hamer, K A Roberti, et al.
Therapeutic Advances in Hematology|March 27, 2026
Ruxolitinib treatment in patients with polycythemia vera reduces <i>JAK2</i> variant allele frequency and improves symptom burden and hematocrit controlClaire N Harrison, Jean-Jacques Kiladjian, J E Hamer-Maansson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1983
Developmental regulation of the Aspergillus nidulans trpC geneM M Yelton, J E Hamer, E R de Souza, et al.
The Plant Cell|June 1, 1996
MPG1 Encodes a Fungal Hydrophobin Involved in Surface Interactions during Infection-Related Development of Magnaporthe griseaN. J. Talbot, M. J. Kershaw, G. E. Wakley, et al.
Cancer|February 25, 2023
Early intervention in myelofibrosis and impact on outcomes: A pooled analysis of the COMFORT-I and COMFORT-II studiesSrdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M Vannucchi, et al.
Diabetes, Obesity & Metabolism|September 10, 2014
Twice-daily dapagliflozin co-administered with metformin in type 2 diabetes: a 16-week randomized, placebo-controlled clinical trialP-M Schumm-Draeger, L Burgess, L Korányi, et al.
Acta Haematologica|July 13, 2025
Impact of Early-Onset or Worsening Anemia in Patients with Myelofibrosis Treated with Ruxolitinib: A post hoc Analysis of the JUMP StudyHaifa Kathrin Al-Ali, Paola Guglielmelli, Claire N Harrison, et al.
The EMBO Journal|December 22, 1999
Interaction between developmental and cell cycle regulators is required for morphogenesis in Aspergillus nidulansX S Ye, S L Lee, T D Wolkow, et al.
Ejhaem|August 19, 2024
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysisMichael R Grunwald, Ellen K Ritchie, Elisa Rumi, et al.
Blood|December 24, 2023
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEALAaron T Gerds, Ruben Mesa, John M Burke, et al.
Pageof 6